Back to discover
Drug

Amylopectin

Research stage
Emerging research

Also known as AMYLOPECTIN, UNSPECIFIED SOURCE.

RxNorm1368128
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Amylopectin
Aliases & brands
AMYLOPECTIN, UNSPECIFIED SOURCE
RxNorm CUI
1368128

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes5
Carbohydrate Metabolism1Diabetes Mellitus, Type 21Eubacteriales1Gastrointestinal Microbiome1Obesity1
Journals, researchers & institutions
Top journals
  • Nature communications1
Leading researchers
  • Ando M1
  • Chen YA1
  • Furuta M1
  • Hosomi K1
  • Kawashima H1
  • Kondo S1
  • Konishi K1
  • Kunisawa J1
Leading institutions
free-text, unnormalised
  • Computational Bio Big-Data Open Innovation Laboratory1
  • Graduate School of Dentistry1
  • Graduate School of Medicine1
  • Graduate School of Pharmaceutical Sciences1
  • Graduate School of Science1
  • Institute for Advanced Research of Biosystem Dynamics1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Ornithine

Studied across 2 of the same disease areas as Amylopectin in the shared literature.

2 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature